239 related articles for article (PubMed ID: 25024090)
21. Review of adjuvant radiochemotherapy for resected pancreatic cancer and results from Mayo Clinic for the 5th JUCTS symposium.
Miller RC; Iott MJ; Corsini MM
Int J Radiat Oncol Biol Phys; 2009 Oct; 75(2):364-8. PubMed ID: 19735864
[TBL] [Abstract][Full Text] [Related]
22. Review and commentary on the role of radiation therapy in the adjuvant management of pancreatic cancer.
Shah AP; Strauss JB; Abrams RA
Am J Clin Oncol; 2010 Feb; 33(1):101-6. PubMed ID: 19636239
[TBL] [Abstract][Full Text] [Related]
23. Role of radiation therapy in the management of pancreatic cancer.
Goodman KA; Hajj C
J Surg Oncol; 2013 Jan; 107(1):86-96. PubMed ID: 22532174
[TBL] [Abstract][Full Text] [Related]
24. Effect of neoadjuvant therapy on local recurrence after resection of pancreatic adenocarcinoma.
Greer SE; Pipas JM; Sutton JE; Zaki BI; Tsapakos M; Colacchio TA; Gibson JJ; Wiener DC; Ripple GH; Barth RJ
J Am Coll Surg; 2008 Mar; 206(3):451-7. PubMed ID: 18308215
[TBL] [Abstract][Full Text] [Related]
25. Significance of histological response to preoperative chemoradiotherapy for pancreatic cancer.
White RR; Xie HB; Gottfried MR; Czito BG; Hurwitz HI; Morse MA; Blobe GC; Paulson EK; Baillie J; Branch MS; Jowell PS; Clary BM; Pappas TN; Tyler DS
Ann Surg Oncol; 2005 Mar; 12(3):214-21. PubMed ID: 15827813
[TBL] [Abstract][Full Text] [Related]
26. [The role of neoadjuvant chemoradiation in pancreatic cancer].
Girard N; Mornex F; Partensky C; Delpero JR
Gastroenterol Clin Biol; 2006 Dec; 30(12):1375-82. PubMed ID: 17211336
[TBL] [Abstract][Full Text] [Related]
27. Two commonly used neoadjuvant chemoradiotherapy regimens for locally advanced stage III non-small cell lung carcinoma: long-term results and associations with pathologic response.
Machtay M; Lee JH; Stevenson JP; Shrager JB; Algazy KM; Treat J; Kaiser LR
J Thorac Cardiovasc Surg; 2004 Jan; 127(1):108-13. PubMed ID: 14752420
[TBL] [Abstract][Full Text] [Related]
28. Adjuvant treatment for resectable pancreatic cancer.
Chua YJ; Cunningham D
J Clin Oncol; 2005 Jul; 23(20):4532-7. PubMed ID: 16002844
[TBL] [Abstract][Full Text] [Related]
29. Pancreatic resections after chemoradiotherapy for locally advanced ductal adenocarcinoma: analysis of perioperative outcome and survival.
Massucco P; Capussotti L; Magnino A; Sperti E; Gatti M; Muratore A; Sgotto E; Gabriele P; Aglietta M
Ann Surg Oncol; 2006 Sep; 13(9):1201-8. PubMed ID: 16955382
[TBL] [Abstract][Full Text] [Related]
30. Adjuvant therapy for pancreatic cancer: an evolving paradigm.
Zhu AX; Clark JW; Willett CG
Surg Oncol Clin N Am; 2004 Oct; 13(4):605-20, viii. PubMed ID: 15350937
[TBL] [Abstract][Full Text] [Related]
31. The case for adjuvant chemoradiation for pancreatic cancer.
Garofalo M; Flannery T; Regine W
Best Pract Res Clin Gastroenterol; 2006 Apr; 20(2):403-16. PubMed ID: 16549335
[TBL] [Abstract][Full Text] [Related]
32. Current view of neoadjuvant chemotherapy in primarily resectable pancreatic adenocarcinoma.
Eid M; Ostřížková L; Kunovský L; Brančíková D; Kala Z; Hlavsa J; Janeček P; Kosíková I; Blažková M; Slabý O; Mayer J
Neoplasma; 2021 Jan; 68(1):1-9. PubMed ID: 32880468
[TBL] [Abstract][Full Text] [Related]
33. [Carcinoma of the pancreas: current status of multimodal therapy].
Keck T
Zentralbl Chir; 2011 Aug; 136(4):352-8. PubMed ID: 21773958
[TBL] [Abstract][Full Text] [Related]
34. Induction chemotherapy improved outcomes of patients with resectable esophageal cancer who received chemoradiotherapy followed by surgery.
Jin J; Liao Z; Zhang Z; Ajani J; Swisher S; Chang JY; Jeter M; Guerrero T; Stevens CW; Vaporciyan A; Putnam J; Walsh G; Smythe R; Roth J; Yao J; Allen P; Cox JD; Komaki R
Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):427-36. PubMed ID: 15380576
[TBL] [Abstract][Full Text] [Related]
35. Multimodality management of localized pancreatic cancer.
Wayne JD; Wolff RA; Pisters PW; Evans DB
Cancer J; 2001; 7 Suppl 1():S35-46. PubMed ID: 11504284
[TBL] [Abstract][Full Text] [Related]
36. Adjuvant 5-FU-based chemoradiotherapy for patients undergoing R-1/R-2 resections for pancreatic cancer.
Smeenk HG; Incrocci L; Kazemier G; van Dekken H; Tran KT; Jeekel J; van Eijck CH
Dig Surg; 2005; 22(5):321-8. PubMed ID: 16254431
[TBL] [Abstract][Full Text] [Related]
37. Neoadjuvant therapy in pancreatic cancer.
Quiros RM; Brown KM; Hoffman JP
Cancer Invest; 2007 Jun; 25(4):267-73. PubMed ID: 17612937
[TBL] [Abstract][Full Text] [Related]
38. Chemoradiotherapy in the treatment of regional pancreatic carcinoma: a phase II study.
Al-Sukhun S; Zalupski MM; Ben-Josef E; Vaitkevicius VK; Philip PA; Soulen R; Weaver D; Adsay V; Heilbrun LK; Levin K; Forman JD; Shields AF
Am J Clin Oncol; 2003 Dec; 26(6):543-9. PubMed ID: 14663369
[TBL] [Abstract][Full Text] [Related]
39. Adjuvant therapy for pancreatic cancer: current status, future directions.
Regine WF; Abrams RA
Semin Oncol; 2006 Dec; 33(6 Suppl 11):S10-3. PubMed ID: 17178279
[TBL] [Abstract][Full Text] [Related]
40. Resection after neoadjuvant therapy for locally advanced, "unresectable" pancreatic cancer.
Strobel O; Berens V; Hinz U; Hartwig W; Hackert T; Bergmann F; Debus J; Jäger D; Büchler MW; Werner J
Surgery; 2012 Sep; 152(3 Suppl 1):S33-42. PubMed ID: 22770956
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
